Product Description
Semaglutide is a long-acting synthetic GLP-1 receptor agonist. It simulates human intestinal incretin hormone, promotes insulin secretion, inhibits glucagon release, delays gastric emptying, reduces appetite and food intake. It achieves stable blood sugar lowering, improves metabolic level, and brings significant body weight loss effect with long half-life, once-weekly injection for convenient use.
Indications
- Adjunctive blood sugar control for adults with Type 2 Diabetes Mellitus
- Chronic weight management for overweight and obese adults
- Improve cardiovascular metabolic risk factors
- Combined with diet and exercise for long-term metabolic regulation
Administration
For subcutaneous injection only, inject into abdomen, thigh or upper arm. Not for intravenous or intramuscular use. Initial dose slow titration, maintenance dose once weekly, follow doctor’s dosage plan strictly.
Product Features
- Long-acting formula, only once a week injection
- Excellent hypoglycemic effect with low hypoglycemia risk
- Obvious fat loss and body weight reduction effect
- Improve insulin resistance and lipid metabolism
- Convenient pre-filled pen design, easy self-injection
Storage
Store in refrigerator at 2°C~8°C, avoid freezing and direct sunlight. Do not freeze, keep away from high temperature environment.
Warnings
- Prescription-only medicine, use under professional doctor supervision
- Contraindicated in personal or family history of medullary thyroid carcinoma
- Contraindicated in hypersensitivity to semaglutide or any excipients
- Common mild reactions: nausea, vomiting, diarrhea, appetite drop, usually relieve gradually
- Not suitable for type 1 diabetes and diabetic ketoacidosis patients
- Pregnancy, lactation and teenagers are prohibited to use
- Keep out of reach of children
